“I get that, CD, I was surmising with ctic why t
Post# of 148190
IMO, the hype from COVID stock to COVID stock is far less then late-spring, early summer, especially with vaccines approaching. Additionally, CYDY has received hype a few times, from the run to $10 to smaller runs from $3.50 to $4.50 as investors hyped conference calls about he M2M data and the S/C 50% interim analysis. Given theses multiple hype runs, with little solid data to report from any of them, investors are more skeptical now and are playing it safe. I believe they’ll be a run up to the release of the 75% interim analysis results, but I don’t believe it will run to $10.